rethinkPeptides Search
Menu
Study breakdown

The Heart Has Its Own Non-Opioid Receptor for Dynorphin That Standard Drugs Can't Touch

In VitroPreliminary evidence
The takeaway

Rat heart membranes have a dynorphin A binding site that is not blocked by standard opioid ligands, is trypsin-sensitive, and inhibited by zinc and magnesium ions.

Non-opioid receptor

Standard opioid drugs cannot compete for this cardiac dynorphin binding site — it's a completely different receptor system

What the researchers found

Rat heart has a non-opioid dynorphin A(1-13) binding site: Kd 285 nM, Bmax 215 pmol/mg protein. Trypsin-sensitive. Inhibited by Zn2+ and Mg2+. Standard opioid ligands do not compete.

Why it matters

The heart responding to dynorphin through a non-opioid receptor means opioid peptides affect the heart in ways that standard opioid drugs cannot block or mimic. This could explain some cardiac effects of opioid peptides.

How the study worked

Membrane binding assays using tritiated dynorphin A(1-13) on rat heart membrane preparations. Competition studies with opioid and non-opioid ligands. Characterization with enzyme treatment and divalent cations.

What this study cannot tell us

In vitro binding study. Shows receptor presence but not function. The biological effects of activating this non-opioid site were not tested. Rat heart may differ from human.

How to read the evidence

Preliminary — in vitro binding study characterizing receptor pharmacology. Demonstrates existence but not biological function.

When this study was published

Published in 1993 (33 years ago). Non-opioid actions of opioid peptides continue to be an active research area.

The bigger picture

If the heart has its own non-opioid dynorphin receptor, this could explain cardiac effects of opioid peptides that aren't mediated by standard opioid drugs. It also means there's an entirely unexplored drug target in the heart.

Questions still open

  • What cardiac functions does this non-opioid dynorphin receptor regulate?
  • Could targeting this receptor treat heart conditions without affecting pain pathways?

Common questions

What is a non-opioid dynorphin receptor?
While dynorphin normally acts on kappa opioid receptors in the brain, this cardiac binding site is completely different — standard opioid drugs don't interact with it. It represents an unknown signaling system in the heart.
Why does the heart need its own dynorphin receptor?
Opioid peptides have effects on heart rate and blood pressure. A non-opioid cardiac receptor could mediate effects that are independent of the classical opioid pain system, potentially regulating heart function in ways we don't yet understand.

Read the original research

Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.

Journal of molecular and cellular cardiology, 25(8), 983-91

Citation

Dumont, M; Lemaire, S. (1993). Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.. Journal of molecular and cellular cardiology, 25(8), 983-91.